CFDE Data Portal | Search PDZRN3

	Label	Description
	PDZRN3 Gene (Entity type)	ENSG00000121440 - PDZ domain containing ring finger 3
	PDZRN3 associations Collection (Entity type)	Associations for PDZRN3_associations
	PDZRN3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PDZRN3-AS1 associations Collection (Entity type)	Associations for PDZRN3-AS1_associations
	PDZRN3-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PDZRN3-AS1 Gene (Entity type)	ENSG00000239677 - PDZRN3 antisense RNA 1
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 trametinib NF1 8 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS

PDZRN3

ENSG00000121440 - PDZ domain containing ring finger 3

PDZRN3 associations

Associations for PDZRN3_associations

PDZRN3 associations.tsv

A file from IDG as part of the Harmonizome project

PDZRN3-AS1 associations

Associations for PDZRN3-AS1_associations

PDZRN3-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

PDZRN3-AS1

ENSG00000239677 - PDZRN3 antisense RNA 1

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN

A Gene Set from LINCS

GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP

A Gene Set from LINCS

GSE213588 trametinib NF1 8 v 11 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.